Get the Stockscreener App
38.14
0.45%
0.08
Omnicell Inc stock is traded at $38.14, with a volume of 120.66K.
It is up +0.45% in the last 24 hours and down -11.95% over the past month.
Omnicell Inc provides automation and business analytics software for healthcare providers. It helps its customers to define and deliver cost-effective medication management that is designed to equip and empower pharmacists and nurses to focus on patient care rather than administrative tasks, and to drive improved clinical, operational, and financial outcomes across all care settings. Omnicell generates the vast majority of its revenue in the United States.
See More
Previous Close:
$38.06
Open:
$37.99
24h Volume:
120.66K
Relative Volume:
0.28
Market Cap:
$1.78B
Revenue:
$1.08B
Net Income/Loss:
$-20.76M
P/E Ratio:
-82.91
EPS:
-0.46
Net Cash Flow:
$151.63M
1W Performance:
-4.01%
1M Performance:
-11.95%
6M Performance:
-13.11%
1Y Performance:
+45.04%
1-Day Range:
$37.81
$38.78
1-Week Range:
$37.69
$40.42
52-Week Range:
$25.12
$55.74
Omnicell Inc Stock (OMCL) Company Profile
Name
Omnicell Inc
Sector
Industry
Phone
(877) 415-9990
Address
4220 NORTH FREEWAY, FORT WORTH
Compare OMCL with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
OMCL
Omnicell Inc
|
38.12 | 1.78B | 1.08B | -20.76M | 151.63M | -0.46 |
|
VEEV
Veeva Systems Inc
|
221.58 | 35.98B | 2.66B | 665.91M | 1.08B | 4.05 |
|
SOLV
Solventum Corp
|
81.20 | 13.98B | 8.26B | 66.00M | 1.17B | 0.3682 |
|
DOCS
Doximity Inc
|
69.94 | 12.92B | 516.85M | 174.11M | 217.38M | 0.87 |
|
TEM
Tempus Ai Inc
|
53.75 | 9.36B | 640.44M | -743.28M | -206.93M | -11.29 |
|
HQY
Healthequity Inc
|
108.73 | 9.34B | 1.15B | 96.70M | -161.99M | 1.09 |
Omnicell Inc Stock (OMCL) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Oct-31-24 | Downgrade | BofA Securities | Buy → Neutral |
| Aug-02-24 | Upgrade | Barclays | Underweight → Equal Weight |
| Jan-03-24 | Initiated | Barclays | Underweight |
| Nov-03-23 | Downgrade | BTIG Research | Buy → Neutral |
| Nov-03-23 | Upgrade | Piper Sandler | Neutral → Overweight |
| Nov-03-23 | Upgrade | Wells Fargo | Underweight → Equal Weight |
| Oct-11-23 | Downgrade | KeyBanc Capital Markets | Overweight → Sector Weight |
| Sep-26-23 | Reiterated | Wells Fargo | Underweight |
| Aug-02-23 | Downgrade | Piper Sandler | Overweight → Neutral |
| Jul-20-23 | Downgrade | Wells Fargo | Overweight → Underweight |
| Feb-27-23 | Upgrade | The Benchmark Company | Hold → Buy |
| Nov-03-22 | Downgrade | The Benchmark Company | Buy → Hold |
| Sep-16-22 | Initiated | KeyBanc Capital Markets | Overweight |
| Sep-09-22 | Initiated | BofA Securities | Buy |
| Jul-15-22 | Initiated | SVB Leerink | Mkt Perform |
| Dec-06-21 | Resumed | Wells Fargo | Overweight |
| Jun-09-21 | Initiated | JP Morgan | Neutral |
| May-24-21 | Initiated | BTIG Research | Buy |
| Feb-02-21 | Upgrade | Piper Sandler | Neutral → Overweight |
| Dec-08-20 | Initiated | Berenberg | Buy |
| Dec-03-20 | Downgrade | Cantor Fitzgerald | Overweight → Neutral |
| Jul-07-20 | Initiated | Stephens | Overweight |
| Feb-07-20 | Reiterated | Dougherty & Company | Buy |
| Nov-21-19 | Reiterated | Dougherty & Company | Buy |
| Jul-26-19 | Upgrade | Craig Hallum | Hold → Buy |
| Mar-07-19 | Reiterated | Dougherty & Company | Buy |
| Jun-29-18 | Resumed | The Benchmark Company | Buy |
| Sep-05-17 | Reiterated | The Benchmark Company | Buy |
| Jul-28-17 | Reiterated | Dougherty & Company | Buy |
| Apr-21-17 | Downgrade | Piper Jaffray | Overweight → Neutral |
| Jan-19-17 | Initiated | Dougherty & Company | Buy |
| Dec-06-16 | Reiterated | The Benchmark Company | Buy |
| Jul-07-16 | Reiterated | FBR Capital | Outperform |
| Mar-21-16 | Reiterated | Topeka Capital Markets | Buy |
| Jan-07-16 | Initiated | The Benchmark Company | Buy |
| Nov-16-15 | Reiterated | Topeka Capital Markets | Buy |
| Oct-30-15 | Reiterated | FBR Capital | Outperform |
| Sep-28-15 | Upgrade | Sidoti | Neutral → Buy |
| Jul-31-15 | Reiterated | Topeka Capital Markets | Buy |
View All
Omnicell Inc Stock (OMCL) Latest News
Omnicell FY2027 EPS Estimate Reduced by Zacks Research - MarketBeat
Principal Financial Group Inc. Raises Holdings in Omnicell, Inc. (NASDAQ:OMCL) - MarketBeat
Wakefield Asset Management LLLP Takes Position in Omnicell, Inc. (NASDAQ:OMCL) - MarketBeat
Zacks Research Forecasts Omnicell FY2027 Earnings - MarketBeat
South Dakota Investment Council Sells 11,000 Shares of Omnicell, Inc. (NASDAQ:OMCL) - MarketBeat
Decoding Omnicell Inc (OMCL): A Strategic SWOT Insight - GuruFocus.com
Is it Apt to Retain Omnicell Stock in Your Portfolio Now? - Nasdaq
Investor Network: Omnicell, Inc. to Host Earnings Call - ACCESS Newswire
OMNICELL, INC. SEC 10-K Report - TradingView
Omnicell, Inc. to Host Earnings Call - ACCESS Newswire
Zacks Research Predicts Omnicell's Q1 Earnings (NASDAQ:OMCL) - MarketBeat
Privia Health (PRVA) Q4 Earnings Report Preview: What To Look For - The Globe and Mail
Omnicell (OMCL) Upgraded to Buy: What Does It Mean for the Stock? - MSN
6,681 Shares in Omnicell, Inc. (NASDAQ:OMCL) Bought by Vontobel Holding Ltd. - MarketBeat
Pharmacy Automation Market Is Booming Worldwide 2025-2032 | - openPR
Omnicell (OMCL) Introduces Central Med Automation Service - MSN
Martin & Co. Inc. TN Sells 10,302 Shares of Omnicell, Inc. (NASDAQ:OMCL) - MarketBeat
Empowered Funds LLC Makes New $388,000 Investment in Omnicell, Inc. (NASDAQ:OMCL) - MarketBeat
Evolent Health (EVH) Q4 Earnings Report Preview: What To Look For - The Globe and Mail
Medication Management System Market Future Business - openPR
Rice Hall James & Associates LLC Raises Stock Holdings in Omnicell, Inc. (NASDAQ:OMCL) - MarketBeat
Omnicell's SWOT analysis: healthcare tech firm's stock faces growth hurdles - MSN
Omnicell's SWOT analysis: healthcare tech firm's stock faces growth hurdles By Investing.com - Investing.com Nigeria
Central Fill Pharmacy Automation Market Poised for Booming - openPR
Global Automated Dispensing Systems Market Size, Share, - openPR
Shaker Investments LLC OH Invests $550,000 in Omnicell, Inc. (NASDAQ:OMCL) - MarketBeat
Sumitomo Mitsui Trust Group Inc. Acquires 699,925 Shares of Omnicell, Inc. (NASDAQ:OMCL) - MarketBeat
Why Omnicell's (NASDAQ:OMCL) Earnings Are Better Than They Seem - Simply Wall St
Omnicell's (NASDAQ:OMCL) Solid Earnings Have Been Accounted For Conservatively - Yahoo Finance
IBD Rating Upgrades: Omnicell Shows Improved Technical Strength - MSN
Wall Street Analysts Think Omnicell (OMCL) Could Surge 29.03%: Read This Before Placing a Bet - MSN
Omnicell Q4 Earnings: Ignore The Short Term Noise (NASDAQ:OMCL) - Seeking Alpha
Exponential Growth Expected for Automated IV Pharmacy - openPR
Omnicell’s Earnings Call Highlights Growth Amid Challenges - TipRanks
Omnicell (NASDAQ:OMCL) Shares Gap Down After Earnings Miss - MarketBeat
Omnicell Q4 Earnings & Revenues Beat, Stock Up, Gross Margin Rises - Yahoo Finance
Omnicell (NASDAQ:OMCL) Issues FY 2025 Earnings Guidance - MarketBeat
Results: Omnicell, Inc. Exceeded Expectations And The Consensus Has Updated Its Estimates - Simply Wall St
Omnicell, Inc. Just Beat EPS By 47%: Here's What Analysts Think Will Happen Next - Yahoo Finance
Omnicell (NASDAQ:OMCL) Releases Q1 2025 Earnings Guidance - MarketBeat
Omnicell's (OMCL) Buy Rating Reaffirmed at Benchmark - MarketBeat
Omnicell projects $1.105M to $1.155M revenue growth in 2025 with XT Amplify momentum - MSN
Omnicell (NASDAQ:OMCL) Issues Quarterly Earnings Results, Misses Estimates By $0.12 EPS - MarketBeat
Omnicell (OMCL) Tops Q4 Earnings and Revenue Estimates - MSN
Omnicell, Inc. (NASDAQ:OMCL) Q4 2024 Earnings Call Transcript - Insider Monkey
Omnicell (NASDAQ:OMCL) Could Be Struggling To Allocate Capital - Yahoo Finance
Omnicell Inc (OMCL) Q4 2024 Earnings Call Highlights: Strong Rev - GuruFocus.com
Omnicell Inc (OMCL) Q4 2024 Earnings Call Highlights: Strong Revenue Growth and Strategic ... - Yahoo Finance
Omnicell Inc Stock (OMCL) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.96%
0.27%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):